StreetInsider.com News Articles

Form 144 CG Oncology, Inc. Filed by: POST LEONARD E

Thu, 15 Oct 2026 16:41:00 -0400

si-local-file:///var/storage/secattach/20261015/27193907.html

CG Oncology names Isabel Kalofonos as chief commercial officer

Tue, 13 Oct 2026 08:01:37 -0400

CG Oncology (NASDAQ: CGON) has appointed Isabel Kalofonos as Chief Commercial Officer, according to a company statement. Kalofonos will oversee commercial strategy and execution as the company prepares for a potential launch of its investigational therapy cretostimogene grenadenorepvec.

Kalofonos brings more than 20 years of biopharmaceutical commercial experience. She most recently served as Chief Commercial Officer at Crinetics Pharmaceuticals, which was acquired by Vertex Pharmaceuticals, where she helped lead the launch of PALSONIFY (paltusotine). Before that, she held the same role at ImmunoGen, which was acquired by AbbVie, where she led the launch of ELAHERE (mirvetuximab soravtansine) for ovarian cancer.

Earlier in

CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer

Tue, 13 Oct 2026 08:00:00 -0400

DALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced the appointment of Isabel Kalofonos as Chief Commercial Officer. A highly accomplished biopharmaceutical executive with more than 20 years of commercial leadership experience, Ms. Kalofonos will lead the Company's commercial strategy and execution as CG Oncology advances toward the potential launch of cretostimogene grenadenorepvec and continues to establish itself as a leader in bladder cancer.

"Isabel’s appointment reflects our commitment to ensuring we are well positioned to bring cretostimogene to as many patients as possible upon approval," said Arthur Kuan, Chairman

CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer

Tue, 13 Oct 2026 08:00:00 -0400

"Isabel’s appointment reflects our commitment to ensuring we are well positioned to bring cretostimogene to as many patients as possible upon approval," said Arthur Kuan, Chairman

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Mon, 21 Sep 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260921/27085340.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Thu, 17 Sep 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260917/27076357.html

Form 4 CG Oncology, Inc. For: Sep 15 Filed by: POST LEONARD E

Thu, 17 Sep 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260917/27076273.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Fri, 11 Sep 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260911/27053642.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Thu, 27 Aug 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260827/26991128.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Thu, 27 Aug 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260827/26991128.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Tue, 25 Aug 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260825/26975262.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Tue, 25 Aug 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20260825/26975262.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Mon, 24 Aug 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260824/26969089.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Mon, 24 Aug 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20260824/26969089.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Wed, 19 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260819/26950038.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Wed, 19 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260819/26950038.html

Form 4 CG Oncology, Inc. For: Aug 14 Filed by: POST LEONARD E

Tue, 18 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260818/26944759.html

Form 4 CG Oncology, Inc. For: Aug 14 Filed by: POST LEONARD E

Tue, 18 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260818/26944759.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Mon, 17 Aug 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260817/26938029.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Mon, 17 Aug 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260817/26938029.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Fri, 14 Aug 2026 19:00:00 -0400

si-local-file:///var/storage/secattach/20260814/26933182.html

Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw

Fri, 14 Aug 2026 19:00:00 -0400

si-local-file:///var/storage/secattach/20260814/26933182.html

Form SCHEDULE 13G/A CG Oncology, Inc. Filed by: Foresite Capital Fund V, L.P.

Fri, 14 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260814/26929949.html

Form SCHEDULE 13G/A CG Oncology, Inc. Filed by: Foresite Capital Fund V, L.P.

Fri, 14 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260814/26929949.html

Form SCHEDULE 13G/A CG Oncology, Inc. Filed by: RTW INVESTMENTS, LP

Fri, 14 Aug 2026 07:58:00 -0400

si-local-file:///var/storage/secattach/20260814/26924699.html